» Articles » PMID: 21057933

γ-H2AX Detection in Peripheral Blood Lymphocytes, Splenocytes, Bone Marrow, Xenografts, and Skin

Overview
Specialty Molecular Biology
Date 2010 Nov 9
PMID 21057933
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

Measurement of DNA double-strand break (DSB) levels in cells is useful in many research areas, including those related to DNA damage and repair, tumorigenesis, anti-cancer drug development, apoptosis, radiobiology, environmental effects, and aging, as well as in the clinic. DSBs can be detected in the nuclei of cultured cells and tissues with an antibody to H2AX phosphorylated on serine residue 139 (γ-H2AX). DSB levels can be obtained either by measuring overall γ-H2AX protein levels in a cell population or by counting γ-H2AX foci in individual nuclei. Total levels can be obtained in extracts of cell populations by immunoblot analysis, and in cell populations by flow cytometry. Furthermore, with flow cytometry, the cell cycle distribution of a population can be obtained in addition to DSB levels, which is an advantage when studying anti-cancer drugs targeting replicating tumor cells. These described methods are used in genotoxicity assays of compounds of interest or in analyzing DSB repair after exposure to drugs or radiation. Immunocyto/immunohistochemical analysis can detect γ-H2AX foci in individual cells and is very sensitive (a single DSB can be visualized), permitting the use of extremely small samples. Measurements of γ-H2AX focal numbers can reveal subtle changes found in the radiation-induced tissue bystander response, low dose radiation exposure, and in cells with mutations in genomic stability maintenance pathways. In addition, marking DNA DSBs in a nucleus with γ-H2AX is a powerful tool to identify novel DNA repair proteins by their abilities to co-localize with γ-H2AX foci at the DSB site. This chapter presents techniques for γ-H2AX detection in a variety of human and mouse samples.

Citing Articles

Heterogeneous Formation of DNA Double-Strand Breaks and Cell-Free DNA in Leukemia T-Cell Line and Human Peripheral Blood Mononuclear Cells in Response to Topoisomerase II Inhibitors.

Linke C, von Hanisch T, Schroder J, Dammermann W, Deckert P, Reinwald M Cancers (Basel). 2024; 16(22).

PMID: 39594753 PMC: 11592837. DOI: 10.3390/cancers16223798.


Determination of dose-response calibration curves for gamma radiation using gamma-H2AX immunofluorescence based biodosimetry.

Jose S, Timothy P, Suganthy J, Backianathan S, Amirtham S, Rani S Rep Pract Oncol Radiother. 2024; 29(2):164-175.

PMID: 39143968 PMC: 11321778. DOI: 10.5603/rpor.99678.


DNA Damage by Radiopharmaceuticals and Mechanisms of Cellular Repair.

Khazaei Monfared Y, Heidari P, Klempner S, Mahmood U, Parikh A, Hong T Pharmaceutics. 2023; 15(12).

PMID: 38140100 PMC: 10748326. DOI: 10.3390/pharmaceutics15122761.


Prediction of late adverse events in pelvic cancer patients receiving definitive radiotherapy using radiation-induced gamma-H2AX foci assay.

Someya M, Hasegawa T, Nakamura A, Tsuchiya T, Kitagawa M, Gocho T J Radiat Res. 2023; 64(6):948-953.

PMID: 37839163 PMC: 10665300. DOI: 10.1093/jrr/rrad079.


Combined inhibition of EZH2 and ATM is synthetic lethal in BRCA1-deficient breast cancer.

Ratz L, Brambillasca C, Bartke L, Huetzen M, Goergens J, Leidecker O Breast Cancer Res. 2022; 24(1):41.

PMID: 35715861 PMC: 9206299. DOI: 10.1186/s13058-022-01534-y.